- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of pneumococcal disease
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 819KB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 369KB)
Pneumococcal conjugate vaccine, 15 valent adsorbed – March 2023
Pneumococcal conjugate vaccine, 15 valent adsorbed: 0.5 mL pre-filled syringe; Vaxneuvance®
Last updated
30 June 2023